SLC5A8
Sodium-coupled monocarboxylate transporter 1 is a protein that in humans is encoded by the SLC5A8 gene.[4][5][6]
See also
References
- ↑ "Drugs that physically interact with Sodium-coupled monocarboxylate transporter 1 view/edit references on wikidata".
- ↑ "Human PubMed Reference:".
- ↑ "Mouse PubMed Reference:".
- ↑ Rodriguez AM, Perron B, Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart JM, Pourcher T (Jul 2002). "Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes". J Clin Endocrinol Metab. 87 (7): 3500–3. doi:10.1210/jc.87.7.3500. PMID 12107270.
- ↑ Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, Willis J, Willson JK, Plass C, Markowitz SD (Jul 2003). "SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers". Proc Natl Acad Sci U S A. 100 (14): 8412–7. doi:10.1073/pnas.1430846100. PMC 166243. PMID 12829793.
- ↑ "Entrez Gene: SLC5A8 solute carrier family 5 (iodide transporter), member 8".
Further reading
- Gupta N, Martin PM, Prasad PD, Ganapathy V (2006). "SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter". Life Sci. 78 (21): 2419–25. doi:10.1016/j.lfs.2005.10.028. PMID 16375929.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Miyauchi S, Gopal E, Fei YJ, Ganapathy V (2004). "Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids". J. Biol. Chem. 279 (14): 13293–6. doi:10.1074/jbc.C400059200. PMID 14966140.
- Lacroix L, Pourcher T, Magnon C, et al. (2004). "Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters". J. Clin. Endocrinol. Metab. 89 (3): 1423–8. doi:10.1210/jc.2003-030542. PMID 15001644.
- Hong C, Maunakea A, Jun P, et al. (2005). "Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8". Cancer Res. 65 (9): 3617–23. doi:10.1158/0008-5472.CAN-05-0048. PMID 15867356.
- Paroder V, Spencer SR, Paroder M, et al. (2006). "Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT". Proc. Natl. Acad. Sci. U.S.A. 103 (19): 7270–5. doi:10.1073/pnas.0602365103. PMC 1456061. PMID 16670197.
- Hu S, Liu D, Tufano RP, et al. (2006). "Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer". Int. J. Cancer. 119 (10): 2322–9. doi:10.1002/ijc.22110. PMID 16858683.
- Gopal E, Miyauchi S, Martin PM, et al. (2007). "Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract". Pharm. Res. 24 (3): 575–84. doi:10.1007/s11095-006-9176-1. PMID 17245649.
- Coady MJ, Wallendorff B, Bourgeois F, et al. (2007). "Establishing a Definitive Stoichiometry for the Na+/Monocarboxylate Cotransporter SMCT1". Biophys. J. 93 (7): 2325–31. doi:10.1529/biophysj.107.108555. PMC 1965447. PMID 17526579.
|
---|
|
By group |
---|
| SLC1–10 |
---|
| (1): | |
---|
| (2): | |
---|
| (3): | |
---|
| (4): | |
---|
| (5): | |
---|
| (6): | |
---|
| (7): | |
---|
| (8): | |
---|
| (9): | |
---|
| (10): | |
---|
|
| | SLC11–20 |
---|
| (11): |
- proton coupled metal ion transporter
|
---|
| (12): | |
---|
| (13): |
- human Na+-sulfate/carboxylate cotransporter
|
---|
| (14): | |
---|
| (15): |
- proton oligopeptide cotransporter
|
---|
| (16): |
- monocarboxylate transporter
|
---|
| (17): | |
---|
| (18): | |
---|
| (19): | |
---|
| (20): | |
---|
|
| | SLC21–30 |
---|
| (21): | |
---|
| (22): | |
---|
| (23): |
- Na+-dependent ascorbic acid transporter
|
---|
| (24): | |
---|
| (25): | |
---|
| (26): |
- multifunctional anion exchanger
|
---|
| (27): | |
---|
| (28): |
- Na+-coupled nucleoside transport (SLC28A1
|
---|
| (29): |
- facilitative nucleoside transporter
|
---|
| (30): | |
---|
|
| | SLC31–40 |
---|
| (31): | |
---|
| (32): | |
---|
| (33): | |
---|
| (34): |
- type II Na+-phosphate cotransporter
|
---|
| (35): |
- nucleoside-sugar transporter
-
-
-
-
- SLC35E1
- SLC35E2
- SLC35E3
- SLC35E4
|
---|
| (36): |
- proton-coupled amino-acid transporter
|
---|
| (37): |
- sugar-phosphate/phosphate exchanger
|
---|
| (38): |
- System A & N, sodium-coupled neutral amino-acid transporter
|
---|
| (39): | |
---|
| (40): |
- basolateral iron transporter
|
---|
|
| | SLC41–48 |
---|
| (41): | |
---|
| (42): | |
---|
| (43): |
- Na+-independent, system-L like amino-acid transporter
|
---|
| (44): | |
---|
| (45): |
- Putative sugar transporter
|
---|
| (46): | |
---|
| (47): | |
---|
| (48): | |
---|
|
| | |
|
|
|
|
|
see also solute carrier disorders |